Clinical trial · Observational
Validation of a Screening Scale for Misuse of Opioid Analgesics
Validation of a Screening Scale for the Misuse of Opioid Analgesics in Patients With Chronic Pain Related to Cancer.
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
In oncology, pain is one of the main symptoms of discomfort. It has a significant impact on the quality of life.The use of opioid analgesics is recommended for the treatment of moderate to severe cancer pain.The misuse of opioid analgesics is an international public health problem.Different scales have been developed to help the prescriber screen for the risk of misuse in the general population. Patients with cancer-related pain are also at risk for aberrant opioid-related behaviors, misuse or addiction. The main objectif of this study is to validate of the screening scale for the misuse of opioid analgesics in patients with chronic pain related to cancer. (Prescription Opioid Misuse Index - POMI).
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Opioid Analgesic Adverse Reaction | — | UNRESOLVED | — |
| Pain | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Questionnaires | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- cancer patients
- description
- Questionnaires
- interventionNames
- Other: Questionnaires
Primary outcomes (2)
- measure
- POMI scale score - Prescription Opioid Misuse Index
- timeFrame
- day 1
- description
- 8-item self-assessment scale
- measure
- POMI scale score - Prescription Opioid Misuse Index
- timeFrame
- day 15
- description
- 8-item self-assessment scale
Secondary outcomes (7)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients aged 18 and over, * Patients with chronic cancer-related pain that has been evolving for at least 3 months, * Patients with a regular prescription of at least one opioid analgesic medicine taken daily for at least 1 month, * Patients followed in oncology for an active cancerous pathology. Exclusion Criteria: * Stopping opioid prescriptions on the day of the test phase (no Retest possible), * Patients in the process of weaning (risk of being weaned during the Retest phase), * Patients unable to complete the questionnaire on their own, * Patients followed in a pain or addiction centre, * Patients in terminal palliative situations of their cancer, * Patients with chronic pain that is more disabling than cancer-related pain, * Patients refusing to participate, * Patients under guardianship or curatorship, * Pregnant or breastfeeding patients, * Patient with a language barrier limiting understanding of the questionnaire in French.
References
Publications (0)
Data not yet available